DE279486C - - Google Patents

Info

Publication number
DE279486C
DE279486C DENDAT279486D DE279486DA DE279486C DE 279486 C DE279486 C DE 279486C DE NDAT279486 D DENDAT279486 D DE NDAT279486D DE 279486D A DE279486D A DE 279486DA DE 279486 C DE279486 C DE 279486C
Authority
DE
Germany
Prior art keywords
tab
cam
supporting block
drawer
mandrel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DENDAT279486D
Other languages
German (de)
English (en)
Publication of DE279486C publication Critical patent/DE279486C/de
Active legal-status Critical Current

Links

Classifications

    • E—FIXED CONSTRUCTIONS
    • E05—LOCKS; KEYS; WINDOW OR DOOR FITTINGS; SAFES
    • E05D—HINGES OR SUSPENSION DEVICES FOR DOORS, WINDOWS OR WINGS
    • E05D11/00—Additional features or accessories of hinges
    • E05D11/10—Devices for preventing movement between relatively-movable hinge parts
    • E05D11/1007—Devices for preventing movement between relatively-movable hinge parts with positive locking
    • E—FIXED CONSTRUCTIONS
    • E05—LOCKS; KEYS; WINDOW OR DOOR FITTINGS; SAFES
    • E05Y—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES E05D AND E05F, RELATING TO CONSTRUCTION ELEMENTS, ELECTRIC CONTROL, POWER SUPPLY, POWER SIGNAL OR TRANSMISSION, USER INTERFACES, MOUNTING OR COUPLING, DETAILS, ACCESSORIES, AUXILIARY OPERATIONS NOT OTHERWISE PROVIDED FOR, APPLICATION THEREOF
    • E05Y2900/00—Application of doors, windows, wings or fittings thereof
    • E05Y2900/10—Application of doors, windows, wings or fittings thereof for buildings or parts thereof
    • E05Y2900/13—Type of wing
    • E05Y2900/146—Shutters

Landscapes

  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Operating, Guiding And Securing Of Roll- Type Closing Members (AREA)
DENDAT279486D Active DE279486C (cg-RX-API-DMAC7.html)

Publications (1)

Publication Number Publication Date
DE279486C true DE279486C (cg-RX-API-DMAC7.html)

Family

ID=535397

Family Applications (1)

Application Number Title Priority Date Filing Date
DENDAT279486D Active DE279486C (cg-RX-API-DMAC7.html)

Country Status (1)

Country Link
DE (1) DE279486C (cg-RX-API-DMAC7.html)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE941414C (de) * 1953-07-14 1956-04-12 Hermann Autenrieth Selbsttaetiger Ladenfeststeller
FR2612236A1 (fr) * 1987-03-13 1988-09-16 Dobigny Henri Dispositif permettant de maintenir en position ouverte les vantaux de volets
US5808096A (en) * 1989-04-19 1998-09-15 Enzon, Inc. Process for preparing active carbonates of polyalkylene oxides for modification of polypeptides
US6576235B1 (en) 1998-08-06 2003-06-10 Mountain View Pharmaceuticals, Inc. PEG-urate oxidase conjugates and use thereof
US6783965B1 (en) 2000-02-10 2004-08-31 Mountain View Pharmaceuticals, Inc. Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates
US7056713B1 (en) 1998-08-06 2006-06-06 Duke University Urate oxidase
US7538092B2 (en) 2002-10-08 2009-05-26 Fresenius Kabi Deutschland Gmbh Pharmaceutically active oligosaccharide conjugates
US7541328B2 (en) 2002-03-06 2009-06-02 Fresenius Kabi Deutschland Gmbh Coupling proteins to a modified polysaccharide
US7816516B2 (en) 2001-03-16 2010-10-19 Fresenius Kabi Deutschland Gmbh Conjugates of hydroxyalkyl starch and an active agent
US7815893B2 (en) 2002-09-11 2010-10-19 Fresenius Kabi Deutschland Gmbh Hydroxyalkyl starch derivatives
US9670467B2 (en) 2005-04-11 2017-06-06 Horizon Pharma Rheumatology Llc Variant forms of urate oxidase and use thereof
US10139399B2 (en) 2009-06-25 2018-11-27 Horizon Pharma Rheumatology Llc Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during PEGylated uricase therapy
US12465631B2 (en) 2019-01-30 2025-11-11 Horizon Therapeutics Usa, Inc. Reducing immunogenicity to pegloticase
US12496331B2 (en) 2016-11-11 2025-12-16 Horizon Therapeutics Usa, Inc. Combination therapies of prednisone and uricase molecules and uses thereof

Cited By (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE941414C (de) * 1953-07-14 1956-04-12 Hermann Autenrieth Selbsttaetiger Ladenfeststeller
FR2612236A1 (fr) * 1987-03-13 1988-09-16 Dobigny Henri Dispositif permettant de maintenir en position ouverte les vantaux de volets
US5808096A (en) * 1989-04-19 1998-09-15 Enzon, Inc. Process for preparing active carbonates of polyalkylene oxides for modification of polypeptides
US9885024B2 (en) 1998-08-06 2018-02-06 Duke University PEG-urate oxidase conjugates and use thereof
US6576235B1 (en) 1998-08-06 2003-06-10 Mountain View Pharmaceuticals, Inc. PEG-urate oxidase conjugates and use thereof
US7056713B1 (en) 1998-08-06 2006-06-06 Duke University Urate oxidase
US6783965B1 (en) 2000-02-10 2004-08-31 Mountain View Pharmaceuticals, Inc. Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates
US7816516B2 (en) 2001-03-16 2010-10-19 Fresenius Kabi Deutschland Gmbh Conjugates of hydroxyalkyl starch and an active agent
US7541328B2 (en) 2002-03-06 2009-06-02 Fresenius Kabi Deutschland Gmbh Coupling proteins to a modified polysaccharide
US7815893B2 (en) 2002-09-11 2010-10-19 Fresenius Kabi Deutschland Gmbh Hydroxyalkyl starch derivatives
US7538092B2 (en) 2002-10-08 2009-05-26 Fresenius Kabi Deutschland Gmbh Pharmaceutically active oligosaccharide conjugates
US11781119B2 (en) 2005-04-11 2023-10-10 Horizon Therapeutics Usa, Inc. Variant forms of urate oxidase and use thereof
US11345899B2 (en) 2005-04-11 2022-05-31 Horizon Therapeutics Usa, Inc. Variant forms of urate oxidase and use thereof
US9926537B2 (en) 2005-04-11 2018-03-27 Horizon Pharma Rheumatology Llc Variant forms of urate oxidase and use thereof
US9670467B2 (en) 2005-04-11 2017-06-06 Horizon Pharma Rheumatology Llc Variant forms of urate oxidase and use thereof
US10160958B2 (en) 2005-04-11 2018-12-25 Horizon Pharma Rheumatology Llc Variant forms of urate oxidase and use thereof
US10731139B2 (en) 2005-04-11 2020-08-04 Horizon Pharma Rheumatology Llc Variant forms of urate oxidase and use thereof
US9926538B2 (en) 2005-04-11 2018-03-27 Horizon Pharma Rheumatology Llc Variant forms of urate oxidase and use thereof
US11639927B2 (en) 2009-06-25 2023-05-02 Horizon Therapeutics Usa, Inc. Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during PEGylated uricase therapy
US11598767B2 (en) 2009-06-25 2023-03-07 Horizon Therapeutics Usa, Inc. Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy
US10823727B2 (en) 2009-06-25 2020-11-03 Horizon Pharma Rheumatology Llc Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy
US10139399B2 (en) 2009-06-25 2018-11-27 Horizon Pharma Rheumatology Llc Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during PEGylated uricase therapy
US11982670B2 (en) 2009-06-25 2024-05-14 Horizon Therapeutics Usa, Inc. Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy
US12188927B2 (en) 2009-06-25 2025-01-07 Horizon Therapeutics Usa, Inc. Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during PEGylated uricase therapy
US12560596B2 (en) 2009-06-25 2026-02-24 Amgen Inc. Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy
US12669498B2 (en) 2009-06-25 2026-06-30 Horizon Therapeutics Usa, Inc. Methods and kits for predicting infusion reaction risk and antibody mediated loss of response by monitoring serum uric acid during pegylated uricase therapy
US12496331B2 (en) 2016-11-11 2025-12-16 Horizon Therapeutics Usa, Inc. Combination therapies of prednisone and uricase molecules and uses thereof
US12465631B2 (en) 2019-01-30 2025-11-11 Horizon Therapeutics Usa, Inc. Reducing immunogenicity to pegloticase

Similar Documents

Publication Publication Date Title
DE4240427C1 (de) Preßwerkzeug
DE2342849A1 (de) Befestigungsvorrichtung fuer die trittstufen einer rolltreppe od. dgl
DE324524C (de) Vorrichtung zur Erzeugung von Blutstauungen
DE202017100758U1 (de) Zange
DE319534C (de) Schliesswerkzeug
DE2736037B2 (de) Steigschutzvorrichtung
DE4315956A1 (de) Kondensationsfalle ohne eigene Anschlußvorrichtungen
DE75947C (de) Cylindergelenk für Rohrleitungen mit Dichtung durch Federung
DE3627334A1 (de) Surfbrettsicherung
DE210677C (cg-RX-API-DMAC7.html)
DE149912C (cg-RX-API-DMAC7.html)
DE63127C (de) Taschenverschlufs
DE297566C (cg-RX-API-DMAC7.html)
DE289961C (cg-RX-API-DMAC7.html)
DE181624C (cg-RX-API-DMAC7.html)
DE51092C (de) Sicherbeits-Bügelverschlufs
DE130853C (cg-RX-API-DMAC7.html)
DE160265C (cg-RX-API-DMAC7.html)
DE140570C (cg-RX-API-DMAC7.html)
DE101036C (cg-RX-API-DMAC7.html)
DE174870C (cg-RX-API-DMAC7.html)
DE2656716C2 (de) Halter für Toilettenpapier-Rollen
DE343383C (cg-RX-API-DMAC7.html)
DE245539C (cg-RX-API-DMAC7.html)
DE230697C (cg-RX-API-DMAC7.html)